Anthony Lebiedzinski

Rupesh Parikh

Susan Anderson

Douglas Lane

Glenn West

Keith Devas

David Shakno

Linda Bolton-Weiser

- Prestige Consumer Healthcare (PBH) is a consumer healthcare company with a diversified portfolio of leading over-the-counter brands, targeting **2% to 3% long-term organic growth**.  **[1295947_2147512_1]** 
- The company's strategy focuses on investing for growth, maintaining a strong financial profile with **best-in-class EBITDA margins in the low 30s** and robust free cash flow, and strategic capital allocation.  **[1295947_2147512_2]** 
- PBH's brand-building playbook, including consumer insights, agile marketing, and innovation, has significantly grown e-commerce sales to **over 16% of total sales** from less than 1% in 2016.  **[1295947_2147512_3]** **[1295947_2147512_4]** 
- Capital allocation priorities include investing in existing brands, M&A for **$20 to $50 million revenue brands**, and strategic share repurchases, with a long-term leverage target of **less than three times**.  **[1295947_2147512_5]** **[1295947_2147512_6]** 
- PBH is addressing supply chain issues for its Clear Eyes brand, including the intent to acquire a critical supplier, Pillar Five, expected to close in calendar Q4, and anticipates **$245 million or more in free cash flow** for fiscal 2026.  **[1295947_2147512_6]** **[1295947_2147512_8]**